Viewing Study NCT04922151


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-01-01 @ 7:34 AM
Study NCT ID: NCT04922151
Status: UNKNOWN
Last Update Posted: 2021-06-10
First Post: 2021-06-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module